Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Comparison of pelvic masses score (PMS) and Risk of Malignancy Index (RMI 3) in the evaluation of pelvic masses.

Rossi A, Forzano L, Romanello I, Ambrosini G, Iuri V, Marchesoni D.

Eur J Gynaecol Oncol. 2014;35(4):421-4.

PMID:
25118484
2.

A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS).

Rossi A, Braghin C, Soldano F, Isola M, Capodicasa V, Londero AP, Forzano L, Marchesoni D.

Eur J Obstet Gynecol Reprod Biol. 2011 Jul;157(1):84-8. doi: 10.1016/j.ejogrb.2011.02.009. Epub 2011 Mar 25.

PMID:
21440361
3.

Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.

Alanbay I, Akturk E, Coksuer H, Ercan M, Karaşahin E, Dede M, Yenen MC, Ozan H, Baser I.

Gynecol Endocrinol. 2012 Jun;28(6):478-82. doi: 10.3109/09513590.2011.633663. Epub 2011 Nov 28.

PMID:
22122561
4.

The risk of malignancy with an apparently simple adnexal cyst on ultrasound.

Obwegeser R, Deutinger J, Bernascheck G.

Arch Gynecol Obstet. 1993;253(3):117-20.

PMID:
8250597
5.

Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses.

Peces Rama A, Llanos Llanos MC, Sánchez Ferrer ML, Alcázar Zambrano JL, Martínez Mendoza A, Nieto Díaz A.

Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:7-11. doi: 10.1016/j.ejogrb.2015.07.010. Epub 2015 Aug 20.

PMID:
26461961
6.

The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.

Moolthiya W, Yuenyao P.

Asian Pac J Cancer Prev. 2009;10(5):865-8.

7.

Risk of malignancy index in the preoperative evaluation of pelvic masses.

Obeidat BR, Amarin ZO, Latimer JA, Crawford RA.

Int J Gynaecol Obstet. 2004 Jun;85(3):255-8.

PMID:
15145261
8.

[Transvaginal ultrasonography and nuclear magnetic resonance. Comparison of techniques in the evaluation of ovarian lesions].

Mascaretti G, Carta G, Renzi E, Peluzzi C, Bonitatibus A, Di Francesco CL, Patacchiola F, Moscarini M.

Minerva Ginecol. 1994 Nov;46(11):591-5. Italian.

PMID:
7854561
9.

Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses.

Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T.

Eur J Obstet Gynecol Reprod Biol. 2009 Jun;144(2):163-7. doi: 10.1016/j.ejogrb.2009.02.048. Epub 2009 Mar 27.

PMID:
19327881
10.

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.

Håkansson F, Høgdall EV, Nedergaard L, Lundvall L, Engelholm SA, Pedersen AT, Hartwell D, Høgdall C; DANISH ‘PELVIC MASS’ OVARIAN CANCER STUDY.

Acta Obstet Gynecol Scand. 2012 Apr;91(4):496-502. doi: 10.1111/j.1600-0412.2012.01359.x. Epub 2012 Feb 22.

PMID:
22229703
11.

Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.

Yenen MC, Alanbay I, Aktürk E, Ercan CM, Coksuer H, Karaşahin E, Ozan H, Dede M.

Eur J Gynaecol Oncol. 2012;33(2):168-73.

PMID:
22611957
12.
13.

Risk of malignancy index in preoperative evaluation of pelvic masses.

Ashrafgangooei T, Rezaeezadeh M.

Asian Pac J Cancer Prev. 2011;12(7):1727-30.

14.

Serum C-reactive protein in the differential diagnosis of ovarian masses.

Hefler-Frischmuth K, Hefler LA, Heinze G, Paseka V, Grimm C, Tempfer CB.

Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):65-8. doi: 10.1016/j.ejogrb.2009.06.010. Epub 2009 Jul 19.

PMID:
19619929
15.

[Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses].

Lou HY, Meng H, Zhu QL, Zhang Q, Jiang YX.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Jun;32(3):297-302. doi: 10.3881/j.issn.1000-503X.2010.03.013. Chinese.

16.

External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.

van den Akker PA, Zusterzeel PL, Aalders AL, Snijders MP, Samlal RA, Vollebergh JH, Kluivers KB, Massuger LF.

Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):422-5. doi: 10.1016/j.ejogrb.2011.07.035. Epub 2011 Aug 6.

17.

Comparison of nine morphological scoring systems to detect ovarian malignancy.

Aktürk E, Dede M, Yenen MC, Koçyiğit YK, Ergün A.

Eur J Gynaecol Oncol. 2015;36(3):304-8.

PMID:
26189258
18.

[Diagnosis of ovarian tumors by sonography].

Wu ZY, Zhang GY, Du ZB.

Zhonghua Fu Chan Ke Za Zhi. 1994 Feb;29(2):100-2, 125. Chinese.

PMID:
8033625
19.

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.

Karlsen MA, Sandhu N, Høgdall C, Christensen IJ, Nedergaard L, Lundvall L, Engelholm SA, Pedersen AT, Hartwell D, Lydolph M, Laursen IA, Høgdall EV.

Gynecol Oncol. 2012 Nov;127(2):379-83. doi: 10.1016/j.ygyno.2012.07.106. Epub 2012 Jul 24.

PMID:
22835718
20.

Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.

Numanoglu C, Kuru O, Sakinci M, Akbayır O, Ulker V.

Aust N Z J Obstet Gynaecol. 2013 Jun;53(3):287-92. doi: 10.1111/ajo.12090. Epub 2013 Apr 23.

PMID:
23611791

Supplemental Content

Support Center